Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Polypharmacy with antidepressants in children and adolescents.

Díaz-Caneja CM, Espliego A, Parellada M, Arango C, Moreno C.

Int J Neuropsychopharmacol. 2014 Jul;17(7):1063-82. doi: 10.1017/S1461145712001265. Epub 2012 Nov 29. Review.

PMID:
23190624
2.

Nontricyclic antidepressants: current trends in children and adolescents.

Emslie GJ, Walkup JT, Pliszka SR, Ernst M.

J Am Acad Child Adolesc Psychiatry. 1999 May;38(5):517-28. Review.

PMID:
10230183
3.

Newer generation antidepressants for depressive disorders in children and adolescents.

Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD004851. doi: 10.1002/14651858.CD004851.pub3. Review.

PMID:
23152227
4.

The epidemiology of psychotropic drug use in children and adolescents.

Bonati M, Clavenna A.

Int Rev Psychiatry. 2005 Jun;17(3):181-8. Review.

PMID:
16194789
5.

[Algorithms for the medical treatment of Attention-Deficit/Hyperactivity Disorder with specific co-morbidities].

Frölich J, Lehmkuhl G, Döpfner M.

Z Kinder Jugendpsychiatr Psychother. 2010 Jan;38(1):7-20. doi: 10.1024/1422-4917.a000002. Review. German.

PMID:
20047172
6.

Antidepressants for the treatment of depression in people with cancer.

Ostuzzi G, Matcham F, Dauchy S, Barbui C, Hotopf M.

Cochrane Database Syst Rev. 2015 Jun 1;(6):CD011006. doi: 10.1002/14651858.CD011006.pub2. Review.

PMID:
26029972
7.

Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics.

Correll CU, Kratochvil CJ, March JS.

J Clin Psychiatry. 2011 May;72(5):655-70. doi: 10.4088/JCP.11r07064. Review.

PMID:
21658348
8.

[Psychotropic drugs in general practice].

Zimmer A.

Praxis (Bern 1994). 2014 Jun 18;103(13):763-6. doi: 10.1024/1661-8157/a001692. Review. German.

PMID:
24938158
9.

Review of the efficacy and safety of antidepressants in youth depression.

Cheung AH, Emslie GJ, Mayes TL.

J Child Psychol Psychiatry. 2005 Jul;46(7):735-54. Review.

PMID:
15972068
10.

[Drug therapy and the most common drugs for childhood psychiatric disorders].

Puustjärvi A, Raunio H, Lecklin A, Kumpulainen K.

Duodecim. 2016;132(10):943-50. Review. Finnish.

PMID:
27382830
11.

Combination pharmacotherapy for psychiatric disorders in children and adolescents: prevalence, efficacy, risks and research needs.

Jureidini J, Tonkin A, Jureidini E.

Paediatr Drugs. 2013 Oct;15(5):377-91. doi: 10.1007/s40272-013-0032-6. Review.

PMID:
23757196
12.

[Use of psychotropic drugs in children].

Purper-Ouakil D.

Arch Pediatr. 2008 Dec;15(12):1834-6. doi: 10.1016/j.arcped.2008.09.026. Epub 2008 Nov 7. Review. French.

PMID:
18995997
13.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
14.

Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.

Otasowie J, Castells X, Ehimare UP, Smith CH.

Cochrane Database Syst Rev. 2014 Sep 19;(9):CD006997. doi: 10.1002/14651858.CD006997.pub2. Review.

PMID:
25238582
15.

Atypical antipsychotics for disruptive behaviour disorders in children and youths.

Loy JH, Merry SN, Hetrick SE, Stasiak K.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD008559. doi: 10.1002/14651858.CD008559.pub2. Review.

PMID:
22972123
16.

Child and learning disability psychopharmacology.

[No authors listed]

J Psychopharmacol. 1997;11(4):291-4. Review.

PMID:
9443515
17.

[Current evaluation of teratogenic and fetotoxic effects of psychotropic drugs].

Watanabe O.

Seishin Shinkeigaku Zasshi. 2014;116(12):996-1004. Review. Japanese.

PMID:
25823351
18.

Antidepressant treatments in children and adolescents: II. Anxiety, physical, and behavioral disorders.

Ambrosini PJ, Bianchi MD, Rabinovich H, Elia J.

J Am Acad Child Adolesc Psychiatry. 1993 May;32(3):483-93. Review.

PMID:
8496110
19.

[Critical analysis of controlled pharmacologic studies in obsessive compulsive disorder].

Brochier T, Hantouche E.

Encephale. 1989 May-Jun;15(3):325-33. Review. French.

PMID:
8641159
20.

The use of psychotropic drugs in epilepsy: what every neurologist should know.

Kanner AM.

Semin Neurol. 2008 Jul;28(3):379-88. doi: 10.1055/s-2008-1079342. Epub 2008 Jul 24. Review.

PMID:
18777484

Supplemental Content

Support Center